FDA action counts
| Total FDA actions | 1 |
|---|---|
| Warning letters | 1 |
| Recalls | 0 |
| Approval records | 0 |
| Form 483 inspection citations | 0 |
| Most recent action | April 9, 2026 |
Enforcement history
On 2026-04-09, Argus HQ recorded an FDA Warning Letter for Medical Products Laboratories, Inc., rated "critical" severity in Argus HQ's classification: Medical Products Laboratories, Inc. — CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug (2026-04-09). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. Medical Products Laboratories, Inc. has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Frequently asked questions
- Does Argus HQ track new FDA actions for Medical Products Laboratories, Inc. automatically?
- Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Medical Products Laboratories, Inc. is observed, this page's event count and history update automatically.
- How many FDA actions does Argus HQ track for Medical Products Laboratories, Inc.?
- 1 total: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.
- What is the most recent FDA action on file for Medical Products Laboratories, Inc.?
- April 9, 2026. Argus HQ ingests new FDA enforcement records daily.
- Has Medical Products Laboratories, Inc. received FDA warning letters?
- Yes, 1 warning letter on file. See the full history below for each one.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
- Medical Products Laboratories, Inc. vs Philips North America
- Medical Products Laboratories, Inc. vs Medline Industries, LP
- Medical Products Laboratories, Inc. vs Boston Scientific Corporation
- Medical Products Laboratories, Inc. vs Baxter Healthcare Corporation
- Medical Products Laboratories, Inc. vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Verified from FDA.gov · Last updated: Apr 9, 2026Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Enforcement History: Medical Products Laboratories, Inc.. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/medical-products-laboratories-inc
"FDA Enforcement History: Medical Products Laboratories, Inc.." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/medical-products-laboratories-inc.
Argus HQ Research. "FDA Enforcement History: Medical Products Laboratories, Inc.." Digital Empire Holdings LLC. Accessed August 29, 2026. https://argushq.ai/company/medical-products-laboratories-inc.
@misc{argushq_argushq_ai_company_medical_products_laboratories_inc_2026,
title = {FDA Enforcement History: Medical Products Laboratories, Inc.},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/company/medical-products-laboratories-inc},
note = {Accessed: August 29, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗